npj Vaccines Pharmacology (medical)

A multicenter, dose-ranging human challenge study of a recombinant influenza A (A/Texas/71/2017 (H3N2)) virus in healthy adult volunteers

Micah T. McClain, Christopher Bryant, Ciara Culverhouse-Steadman, Kathleen M. Neuzil, Edwin Wilbur Woodhouse, Franklin R. Toapanta, Georgia D. Tomaras, Meagan E. Deming, Vaidehi Agrawal, Catherine J. Luke, Nicole Yates, Megan F. McGilvray, Sarah Gurley, Bradly Nicholson, Kristen Gunnell, Marcela F. Pasetti, Stephen J. Thomas, Paula J. Bernal, Marcelo B. Sztein, Francisco J. Leyva, Erica L. Sondergaard, Christopher Chiu, Paul C. Roberts, Emmanuel B. Walter, Justin R. Ortiz, Christopher W. Woods
Springer Nature · 2026-11-20 · DOI 10.1038/s41541-026-01601-x

Abstract

npj Vaccines, Published online: 20 November 2026; doi:10.1038/s41541-026-01601-x A multicenter, dose-ranging human challenge study of a recombinant influenza A (A/Texas/71/2017 (H3N2)) virus in healthy adult volunteers

Read at publisher →